LO-007 EZH2 deficiency in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in mice

LO-007 EZH2 deficiency in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in mice

Bibliographic Details
Main Authors:	Sheldon Bastacky, Xiaoqing Zheng, Mikhail Dozmorov, Colleen Strohlein, Amr Sawalha
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	Lupus Science and Medicine

Similar Items

201 Ezh2 knockout in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in MRL/lpr mice
by: Amr H Sawalha, et al.
Published: (2022-12-01)

Autophagy is activated in systemic lupus erythematosus and required for plasmablast development.
by: Clarke, A, et al.
Published: (2015)

LSO-040 Mitochondria promotes autoimmune plasmablasts generation in lupus
by: Jason Jungsik Song, et al.
Published: (2023-07-01)

B cell–intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice
by: Haylee A. Cosgrove, et al.
Published: (2023-08-01)

A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma
by: Vincenzo Sammartano, et al.
Published: (2023-03-01)

Plasmablastic Myeloma- A Diagnostic Dilemma
by: Shiva Kumar Komaravelli, et al.
Published: (2023-05-01)

Plasmablastic lymphoma masked by hidradenitis suppurativa
by: Sarah Preis, MD, et al.
Published: (2022-09-01)

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus
by: Amr H. Sawalha, et al.
Published: (2020-08-01)

SH3BP2 Deficiency Ameliorates Murine Systemic Lupus Erythematosus
by: Kyoko Kawahara, et al.
Published: (2021-04-01)

Clinical subgroup clustering analysis in a systemic lupus erythematosus cohort from Western Pennsylvania
by: Patrick Coit, et al.
Published: (2022-01-01)

Plasmablastic lymphoma in HIV+ patients: an expanding spectrum.
by: Chetty, R, et al.
Published: (2003)

Plasmablastic lymphoma with skin involvement in an immunocompetent male
by: Baixue Lv, et al.
Published: (2023-12-01)

Plasmablastic lymphoma: current knowledge and future directions
by: Ji-Wei Li, et al.
Published: (2024-02-01)

Plasmablastic myeloma progressed to plasma cell leukaemia
by: Ke Xu, et al.
Published: (2021-11-01)

LP-096 Plasmablast-like antigen-experienced CXCR5- CD19low B cells are expanded in systemic lupus erythematosus
by: Tobias Alexander, et al.
Published: (2023-07-01)

PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1)
by: Michele Bibas
Published: (2024-01-01)

Plasmablastic Lymphoma of the Maxillary Sinus Causing Orbital Complication
by: Sedat Aydın, et al.
Published: (2018-09-01)

IgE+ plasmablasts predict the onset of clinical allergy
by: Elisabeth M. Simonin, et al.
Published: (2023-02-01)

Plasmablastic lymphoma with initial presentation in the skin in an old patient
by: Yi-Hsuan Hu, et al.
Published: (2019-01-01)

LSO-007 Trimeric oligonucleotides ameliorate disease in a mouse model of CLE-like inflammatory skin disease
by: Mary Speir, et al.
Published: (2023-07-01)

12.007 Geobiology, Spring 2007
by: Summons, Roger
Published: (2010)

12.007 Geobiology, Spring 2009
by: Summons, Roger, et al.
Published: (2009)

12.007 Geobiology, Spring 2003
by: Sachs, Julian P. (Julian Perelman), et al.
Published: (2003)

Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders.
by: Borenstein, J, et al.
Published: (2007)

Malignant ulcer: a great mimicker of gastric plasmablastic lymphoma
by: Syamim Johan, et al.
Published: (2021)

Gating strategy for plasmablast enumeration after hepatitis B vaccination
by: M. G. Byazrova, et al.
Published: (2021-01-01)

Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement
by: Mohammad Barouqa, et al.
Published: (2022-08-01)

The Janus face of proliferating plasmablasts in dengue and COVID-19 infections
by: Priya Nayak, et al.
Published: (2023-08-01)

Primary refractory plasmablastic lymphoma: A precision oncology approach
by: Hanno M. Witte, et al.
Published: (2023-02-01)

Plasmablastic lymphoma of the upper gingiva in an HIV-negative elderly patient
by: Tomohiro Yamada, DDS, PhD, et al.
Published: (2015-06-01)

Product realization of the 2.007 control box
by: Lin, Wey-Jiun
Published: (2007)

Exportable development of the 2.007 control system
by: Colton, Shane W. (Shane William)
Published: (2009)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
by: Haruka Shinohara, et al.
Published: (2022-12-01)

B‐cell maturation antigen expression and clinical features of plasmablastic lymphoma
by: Ning Dong, et al.
Published: (2024-02-01)

Unraveling the Immunopathogenesis of Multiple Sclerosis: The Dynamic Dance of Plasmablasts and Pathogenic T Cells
by: Yasunari Matsuzaka, et al.
Published: (2023-09-01)

A rare case of HIV-negative plasmablastic lymphoma in nasal cavity
by: Yixing Yao, et al.
Published: (2023-11-01)

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma
by: Martin Vogel, et al.
Published: (2023-05-01)

Endoplasmic reticulum expansion throughout the differentiation of teleost B cells to plasmablasts
by: Esther Morel, et al.
Published: (2023-01-01)

Rare Presentation of Post-Transplant Plasmablastic Lymphoma: Colonic Ulcer With Perforation
by: Chi Yuen Cheung, et al.
Published: (2022-01-01)

EZH2 in Myeloid Malignancies
by: Jenny Rinke, et al.
Published: (2020-07-01)